Skip to main content

Peer Review reports

From: Real-world efficacy of adjuvant therapy for totally resected stage I lung adenocarcinoma patients with pathological high-risk factors: propensity score analysis

Original Submission
23 Oct 2023 Submitted Original manuscript
29 Oct 2023 Reviewed Reviewer Report - Shinkichi Takamori
4 Dec 2023 Reviewed Reviewer Report
3 Feb 2024 Author responded Author comments - Yeye Chen
Resubmission - Version 2
3 Feb 2024 Submitted Manuscript version 2
9 Mar 2024 Reviewed Reviewer Report - Shinkichi Takamori
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
25 Apr 2024 Editorially accepted
8 May 2024 Article published 10.1186/s12893-024-02428-w

You can find further information about peer review here.

Back to article page